Zhejiang Orient Ownership
688298 Stock | 30.90 0.61 2.01% |
Zhejiang |
Zhejiang Stock Ownership Analysis
About 50.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 0.89. In the past many companies with similar price-to-book ratios have beat the market. Zhejiang Orient Gene recorded a loss per share of 2.93. The entity last dividend was issued on the 26th of June 2023. The firm had 1.2:1 split on the 26th of June 2023. For more info on Zhejiang Orient Gene please contact the company at 86 57 2530 3755 or go to https://www.orientgene.com.Zhejiang Orient Outstanding Bonds
Zhejiang Orient issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zhejiang Orient Gene uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zhejiang bonds can be classified according to their maturity, which is the date when Zhejiang Orient Gene has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in Zhejiang Stock
Zhejiang Orient financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Orient security.